Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
APPALACHES
2018-002553-30Phase 2Active
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of palbociclib in breast cancer (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Primary endpoint: 3-year distant recurrence-free interval rate. Started Aug 2018; status: active.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2018-002553-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002553-30.